Jennifer Champoux's most recent trade in Monte Rosa Therapeutics Inc was a trade of 158,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 158,000 | 158,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 35,000 | 65,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 02 Jan 2026 | 2,629 | 62,371 | - | 15.2 | 39,882 | Common Stock |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 30,000 | 30,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Jennifer Champoux | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |